Multiple generics

Multiple Generics is an Australian pharmaceutical company that specializes in the supply and distribution of generic prescription medicines. Originally established as a subsidiary of Apotex Australia, the company became a core part of Arrotex Pharmaceuticals following the landmark 2019 merger between Apotex and Arrow Pharmaceuticals. The company manages an extensive portfolio of off-patent medications, ensuring affordable access to essential treatments for the Australian public. Its product range spans several critical therapeutic areas, including cardiovascular health, neurology, and metabolic disorders. Multiple Generics operates under the broader Arrotex umbrella, which is currently the largest generic pharmaceutical supplier in Australia. The company is recognized for its robust supply chain and its role in supporting the Australian Pharmaceutical Benefits Scheme (PBS).